MiCare Path Fuels National Expansion with Funding and Strategic Acquisition
TECHNOLOGYHEALTH & BEAUTY
MiCare Path virtual care solutions support tens of thousands of patients across a dozen medical specialties nationwide.
The future of continuous patient care is no longer confined to the walls of a doctor’s office. MiCare Path, a leading innovator in virtual care solutions, has announced a major strategic double-down: the successful close of its fourth funding round coupled with the acquisition and integration of Compwell, LLC, a well-established provider of care management and virtual assessments.
These milestones mark a pivotal step in MiCare Path's mission to transform connected, ongoing care delivery in the U.S. By fusing new capital with specialized clinical expertise, the company is poised to redefine how physicians and health systems manage complex patient populations.
The Foundation: Connected, Continuous Care
MiCare Path was founded on the simple yet profound belief that patient care should continue beyond the office visit. The company’s integrated, reimbursable virtual care platform now supports tens of thousands of patients across a dozen medical specialties nationwide. The platform powers essential services like:
Remote Patient Monitoring (RPM)
Remote Therapeutic Monitoring (RTM)
Chronic Care Management (CCM)
Principal Care Management (PCM)
This approach enables care teams to gather continuous, real-time data, improve outcomes, and provide proactive clinical decision-making while significantly reducing the burden on human staff.
The Acquisition: Scaling Clinical Expertise
The strategic acquisition of Compwell, a Tennessee-based provider known for its care management services, immediately strengthens MiCare Path's clinical programs. Compwell brings decades of expertise that will be integrated into MiCare Path’s growing national footprint.
“We started MiCare Path with a belief that patient care should continue beyond the office visit,” said Scott Laster, President and CEO of MiCare Path. “With both the close of this funding round and our acquisition of Compwell, we are now strengthened to scale our national footprint and resourced to support clinicians and patients with a complete, turnkey solution.”
AI and the Health-Digital Future
MiCare Path’s next phase of growth will be fueled by accelerating AI innovation on top of its FDA-registered software platform. The company is strategically expanding its use of advanced AI tools to enhance clinical efficiency, automate key workflows, and drive more proactive, personalized patient care.
This growth is essential as the healthcare industry rapidly shifts toward value-based models, where continuous, connected care is crucial for reducing hospital readmissions and improving overall patient health. MiCare Path is setting a new benchmark for virtual care through its "health-digital" approach—a model that seeks to amplify, rather than replace, the human connection between clinicians and patients.
With this new capital and integrated team, MiCare Path remains focused on a singular mission: equipping partners with the technology and services needed to help thousands of patients benefit from continuous, ongoing care in their everyday lives.